Cure Rare Disease scores IND for first-in-human CRISPR therapeuticR&D, TherapeuticsThe nonprofit biotech Cure Rare Disease (CRD) is headed to the clinic with a CRISPR therapeutic aimed at halting the progression of Duchenne muscular dystrophy in single-patient dosing. Read more August 10, 2022/by BioSpace https://www.pharmalive.com/wp-content/uploads/2022/05/BioSpaceCRISPR5-20-2022.jpg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2022-08-10 12:18:542022-08-10 12:18:54Cure Rare Disease scores IND for first-in-human CRISPR therapeutic
